Found: 16
Select item for more details and to access through your institution.
Smartphone-Based Assessment of Mobility and Manual Dexterity in Adult People with Spinal Muscular Atrophy.
- Published in:
- Journal of Neuromuscular Diseases, 2024, v. 11, n. 5, p. 1049, doi. 10.3233/JND-240004
- By:
- Publication type:
- Article
Macrophage inclusions in cerebrospinal fluid following treatment initiation with antisense oligonucleotide therapies in motor neuron diseases.
- Published in:
- Neurological Research & Practice, 2024, v. 6, n. 1, p. 1, doi. 10.1186/s42466-023-00305-0
- By:
- Publication type:
- Article
Validity and reliability of the German multidimensional fatigue inventory in spinal muscular atrophy.
- Published in:
- Annals of Clinical & Translational Neurology, 2022, v. 9, n. 3, p. 351, doi. 10.1002/acn3.51520
- By:
- Publication type:
- Article
Serum creatine kinase and creatinine in adult spinal muscular atrophy under nusinersen treatment.
- Published in:
- Annals of Clinical & Translational Neurology, 2021, v. 8, n. 5, p. 1049, doi. 10.1002/acn3.51340
- By:
- Publication type:
- Article
Correction: Cognitive performance of adult patients with SMA before and after treatment initiation with nusinersen.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Cognitive performance of adult patients with SMA before and after treatment initiation with nusinersen.
- Published in:
- BMC Neurology, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12883-023-03261-z
- By:
- Publication type:
- Article
Cognitive performance of adult patients with SMA before and after treatment initiation with nusinersen.
- Published in:
- BMC Neurology, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12883-023-03261-z
- By:
- Publication type:
- Article
Cognitive performance of adult patients with SMA before and after treatment initiation with nusinersen.
- Published in:
- BMC Neurology, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12883-023-03261-z
- By:
- Publication type:
- Article
Glial fibrillary acidic protein in cerebrospinal fluid of patients with spinal muscular atrophy.
- Published in:
- Annals of Clinical & Translational Neurology, 2022, v. 9, n. 9, p. 1437, doi. 10.1002/acn3.51645
- By:
- Publication type:
- Article
Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapy.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2021, p. 1, doi. 10.1177/1756286421998902
- By:
- Publication type:
- Article
Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapy.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2021, p. 1, doi. 10.1177/1756286421998902
- By:
- Publication type:
- Article
Affection of Respiratory Muscles in ALS and SMA.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 5, p. 1163, doi. 10.3390/jcm11051163
- By:
- Publication type:
- Article
Impaired diaphragmatic motility in treatment‐naive adult patients with spinal muscular atrophy improved during nusinersen treatment.
- Published in:
- Muscle & Nerve, 2023, v. 68, n. 3, p. 278, doi. 10.1002/mus.27938
- By:
- Publication type:
- Article
Troponin T is elevated in a relevant proportion of patients with 5q-associated spinal muscular atrophy.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-57185-w
- By:
- Publication type:
- Article
Treatment expectations and perception of therapy in adult patients with spinal muscular atrophy receiving nusinersen.
- Published in:
- European Journal of Neurology, 2021, v. 28, n. 8, p. 2582, doi. 10.1111/ene.14902
- By:
- Publication type:
- Article
Increased chitotriosidase 1 concentration following nusinersen treatment in spinal muscular atrophy.
- Published in:
- 2021
- By:
- Publication type:
- journal article